Daymark Wealth Partners LLC Lowers Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Daymark Wealth Partners LLC trimmed its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 97.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 3,526 shares of the pharmacy operator’s stock after selling 119,992 shares during the period. Daymark Wealth Partners LLC’s holdings in Walgreens Boots Alliance were worth $39,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Yousif Capital Management LLC boosted its holdings in Walgreens Boots Alliance by 20.2% during the 4th quarter. Yousif Capital Management LLC now owns 204,023 shares of the pharmacy operator’s stock valued at $1,904,000 after acquiring an additional 34,251 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Walgreens Boots Alliance by 45.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 82,502 shares of the pharmacy operator’s stock worth $794,000 after purchasing an additional 25,962 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Walgreens Boots Alliance by 2.9% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 68,942 shares of the pharmacy operator’s stock valued at $643,000 after purchasing an additional 1,926 shares in the last quarter. Golden State Wealth Management LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Finally, Empowered Funds LLC increased its stake in Walgreens Boots Alliance by 16.5% during the 4th quarter. Empowered Funds LLC now owns 26,084 shares of the pharmacy operator’s stock worth $243,000 after buying an additional 3,685 shares during the period. 58.59% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

WBA has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and lowered their target price for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Wall Street Zen assumed coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a “hold” rating for the company. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $10.59.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina bought 832,258 shares of the business’s stock in a transaction dated Sunday, April 27th. The shares were acquired at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the purchase, the chairman now owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. The trade was a 0.57% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 17.50% of the stock is owned by company insiders.

Walgreens Boots Alliance Trading Down 0.1%

Shares of WBA opened at $11.34 on Thursday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $16.25. The company has a market capitalization of $9.81 billion, a PE ratio of -1.11, a price-to-earnings-growth ratio of 1.31 and a beta of 0.78. The stock has a fifty day moving average of $11.06 and a two-hundred day moving average of $10.63. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating the consensus estimate of $0.53 by $0.10. The firm had revenue of $38.59 billion during the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.20 earnings per share. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.